UBS Maintains Buy on BrightSpring Health, Raises Price Target to $92
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $85 to $92.
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $85 to $92.